This bill clarifies that if a drug shortage causes a formulary drug used for the treatment of serious mental illness to become unavailable, a carrier must approve an equivalent nonformulary drug for the period of time that the formulary drug is unavailable. The bill also eliminates a requirement that an enrollee in a health plan gain access to a clinically appropriate drug not otherwise covered by the health plan.

Statutes affected:
Bill Text LD 1100, SP 460: 24-A.4304, 24-A.4311